Solution nuclear magnetic resonance spectroscopy on a nanostructured diamond chip.

Sensors using nitrogen-vacancy centers in diamond are a promising tool for small-volume nuclear magnetic resonance (NMR) spectroscopy, but the limited sensitivity remains a challenge. Here we show nearly two orders of magnitude improvement in concentration sensitivity over previous nitrogen-vacancy and picoliter NMR studies. We demonstrate NMR spectroscopy of picoliter-volume solutions using a nanostructured diamond chip with dense, high-aspect-ratio nanogratings, enhancing the surface area by 15 times. The nanograting sidewalls are doped with nitrogen-vacancies located a few nanometers from the diamond surface to detect the NMR spectrum of roughly 1 pl of fluid lying within adjacent nanograting grooves. We perform 1H and 19F nuclear magnetic resonance spectroscopy at room temperature in magnetic fields below 50 mT. Using a solution of CsF in glycerol, we determine that 4 ± 2 × 1012 19F spins in a 1 pl volume can be detected with a signal-to-noise ratio of 3 in 1 s of integration.Nitrogen vacancy (NV) centres in diamond can be used for NMR spectroscopy, but increased sensitivity is needed to avoid long measurement times. Kehayias et al. present a nanostructured diamond grating with a high density of NV centres, enabling NMR spectroscopy of picoliter-volume solutions.

Microsecond-resolved SDR-based cavity ring down ellipsometry.

We present an experimental apparatus that allows microsecond-resolved ellipsometric and absorption measurements. The apparatus is based on an optical cavity containing a Dove prism, in which light undergoes total internal reflection (TIR), while the data acquisition is based on software defined radio technology and custom-built drivers. We demonstrate the ability to sense rapid variations in the refractive index above the TIR interface for arbitrarily long times with a temporal resolution of at least 2 µs.

Cavity-enhanced parity-nonconserving optical rotation in metastable Xe and Hg.

We propose the measurement of cavity-enhanced parity-nonconserving (PNC) optical rotation in several transitions of metastable Xe and Hg, including Xe (2P(3/2)(o))6s(2)[3/2](2)(o)→(2P(1/2)(o))6s(2)[1/2](1)(o) and Hg 6s6p (3)P(2)(o)→6s6p (1)P(1)(o), with calculated amplitude ratios of E(1)(PNC)/M1=11×10(-8) and 10×10(-8), respectively. We demonstrate the use of a high-finesse bow-tie cavity with counterpropagating beams and a longitudinal magnetic field, which allows the absolute measurement of chiral optical rotation, with a path length enhancement of about 10(4), necessary for PNC measurement from available column densities of 10(14) cm(-2) for metastable Xe or Hg. Rapid PNC-signal reversal, allowing robust background subtraction, is achieved by shifting the cavity resonance to an opposite polarization mode or by inverting the magnetic field. The precise measurement of isotope and nuclear-spin dependent E(1)(PNC) amplitudes provides a sensitive low-energy test of the standard model.

Efficiency of Ber-EP4 antibody for isolating circulating epithelial tumor cells before RT-PCR detection.

We compared the efficacy of 4 methods for isolating circulating tumor cells: immunocapture with Ber-EP4-coated magnetic beads, density gradient separation, ammonium chloride, and distilled water-mediated erythrocyte lysis. Human blood from healthy volunteers was mixed with serial dilutions of prostate (LNCaP) and liver (HepG2) derived tumor cells. Isolation of circulating tumor cells was followed by reverse transcriptase-polymerase chain reaction with primers specific for prostate-specific antigen and alpha-fetoprotein. Ber-EP4 antigen expression was evaluated by immunohistochemistry in 27 hepatocellular carcinomas and 34 prostate adenocarcinomas. Peripheral blood samples from 12 patients with hepatocellular carcinoma and 10 with prostate adenocarcinoma also were tested. Density gradient separation and Ber-EP4 immunocapture were the most sensitive techniques for isolating circulating tumor cells in in vitro tests. Isolation by density gradient separation was significantly more sensitive than Ber-EP4 immunocapture when applied to peripheral blood samples of patients with cancer, a result consistent with the variable expression of Ber-EP4 antigen that we found by immunohistochemistry in prostate adenocarcinomas and hepatocellular carcinomas.